https://www.gosh.nhs.uk/our-research/our-research-infrastructure/nihr-great-ormond-street-hospital-brc/brc-news/using-new-wearable-technology-monitor-niemann-pick-disease/

Using new wearable technology to monitor Niemann-Pick disease

22 Mar 2016, 4:15 p.m.

Two balls, one orange and red and the other purple, yellow, red and green with 'physio' written across it in black.

A smartphone app, combined with wearable technology, will allow doctors to remotely monitor patients with conditions that limit their ability to voluntarily move their muscles. The app, known as 'aparito', uses a motion-tracking writsband to record the movements of patients with ataxia, and other related ambulatory conditions.

The data from the tracker is sent via a smartphone app, where it can be combined with other information such as medication adherence and events such as falls or seizures. Healthcare professionals can have constant access to this information via the web.

Great Ormond Street BRC-researcher Professor Paul Gissen, has been working closely with aparito, and Great Ormond Street Hospital is to be the first in the UK to use this new wearable technology in clinical practice. Patients could receive fewer tests and have shorter hospital visits by using the app, which will monitor routine activity in a continuous, non-invasive way.

New Director Designate announced for NIHR GOSH Biomedical Research Centre

Professor Paul Gissen has been announced as the Director Designate of the NIHR GOSH Biomedical Research Centre.

Study linking data from 85% of children in England compares rare cardiac risks post-COVID vs vaccination

Celebrating research that transforms lives

The 2025 NIHR GOSH BRC Showcase recently celebrated some incredible progress made in paediatric research.

Landmark gene therapy study shows safety for children

Results from the largest cohort of children who received a gene therapy for a rare immunodeficiency condition have shown the long-term safety and efficacy of the curative treatment.